Health Information Technology System ("Roadmap 2.0") in the Context of Hematopoietic Cell Transplantation

Completed · Not applicable

Conditions studied: Hematologic Diseases

In brief

The purpose of this research study is to measure the effects of using a mobile phone app (Roadmap 2.0) on the health-related quality of life of caregivers and patients undergoing allogeneic/autologous hematopoietic cell transplantation (HCT).

Key facts

Study ID
NCT04094844
Run by
University of Michigan Rogel Cancer Center
People needed
372
Starts
2020-09-08
Expected to finish
2024-08-11
Last updated by the study team
2026-04-14

Who can join

Age: 5 and older, up to 75. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.